...
首页> 外文期刊>ACS medicinal chemistry letters >Multicomponent Synthesis and Biological Evaluation of a Piperazine-Based Dopamine Receptor Ligand Library
【24h】

Multicomponent Synthesis and Biological Evaluation of a Piperazine-Based Dopamine Receptor Ligand Library

机译:哌嗪基多巴胺受体配体库的多组分合成及生物学评价

获取原文
获取原文并翻译 | 示例
           

摘要

A series of 1,4-disubstituted piperazine-based compounds were designed, synthesized, and evaluated as dopamine D2/D3 receptor ligands. The synthesis relies on the key multicomponent split-Ugi reaction, assessing its great potential in generating chemical diversity around the piperazine core. With the aim of evaluating the effect of such diversity on the dopamine receptor affinity, a small library of compounds was prepared, applying post-Ugi transformations. Ligand stimulated binding assays indicated that some compounds show a significant affinity, with K-i values up to 53 nM for the D2 receptor. Molecular docking studies with the D2 and D3 receptor homology models were also performed on selected compounds. They highlighted key interactions at the indole head and at the piperazine moiety, which resulted in good agreement with the known pharmacophore models, thus helping to explain the observed structure-activity relationship data. Molecular insights from this study could enable a rational improvement of the split-Ugi primary scaffold, toward more selective ligands.
机译:设计,合成和评估了一系列基于1,4-二取代哌嗪的化合物,作为多巴胺D2 / D3受体配体。该合成依赖于关键的多组分拆分-Ugi反应,评估了其在哌嗪核心周围产生化学多样性的巨大潜力。为了评估这种多样性对多巴胺受体亲和力的影响,使用Ugi后转化制备了一个小型化合物库。配体刺激的结合测定表明某些化合物显示出显着的亲和力,对于D2受体的K-i值高达53 nM。还对选定的化合物进行了D2和D3受体同源性模型的分子对接研究。他们强调了在吲哚头和哌嗪部分的关键相互作用,这与已知的药效团模型具有很好的一致性,从而有助于解释观察到的结构-活性关系数据。这项研究的分子洞察力可以使分裂的Ugi主支架朝着更具选择性的配体的方向合理地改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号